Agios Pharmaceuticals (AGIO)
(Real Time Quote from BATS)
$34.37 USD
+0.36 (1.06%)
Updated Feb 5, 2025 12:02 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Agios Pharmaceuticals (AGIO) Price Targets
| Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
|---|---|---|---|
| $56.86 | $75.00 | $46.00 | 67.19% |
Find the top stocks with the greatest target price potential and Zacks Rank of 1 or 2
Price Target
Based on short-term price targets offered by seven analysts, the average price target for Agios Pharmaceuticals comes to $56.86. The forecasts range from a low of $46.00 to a high of $75.00. The average price target represents an increase of 67.19% from the last closing price of $34.01.
Analyst Price Targets (7 )
Broker Rating
Agios Pharmaceuticals currently has an average brokerage recommendation (ABR) of 1.78 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by nine brokerage firms. The current ABR compares to an ABR of 1.78 a month ago based on nine recommendations.
Of the nine recommendations deriving the current ABR, five are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 55.56% and 11.11% of all recommendations. A month ago, Strong Buy made up 55.56%, while Buy represented 11.11%.
Broker Rating Breakdown
Brokerage Recommendations
| Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 2 | 2 |
| Hold | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| ABR | 1.78 | 1.78 | 1.78 | 1.80 | 1.80 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
| Date | Brokerage Firm | Analyst | Previous | Current |
|---|---|---|---|---|
| 11/1/2024 | Cowen & Co. | Marc Frahm | Strong Buy | Strong Buy |
| 10/16/2024 | Scotiabank | Greg Harrison | Not Available | Strong Buy |
| 9/27/2024 | SVB Securities | Andrew Berens | Strong Buy | Hold |
| 9/20/2024 | Cantor Fitzgerald & Co | Eric Schmidt | Strong Buy | Strong Buy |
| 9/19/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
| 5/3/2024 | Goldman Sachs | Salveen Richter | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
| Current ABR | 1.78 |
| ABR (Last week) | 1.78 |
| # of Recs in ABR | 9 |
| Average Target Price | $56.86 |
| LT Growth Rate | 11.20% |
| Industry | Medical - Biomedical and Genetics |
| Industry Rank by ABR | 73 of 251 |
| Current Quarter EPS Est: | -1.74 |
AGIO FAQs
Agios Pharmaceuticals, Inc. (AGIO) currently has an average brokerage recommendation (ABR) of 1.78 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 9 brokerage firms.
The average price target for Agios Pharmaceuticals, Inc. (AGIO) is $56.86. The current on short-term price targets is based on 7 reports.
The forecasts for Agios Pharmaceuticals, Inc. (AGIO) range from a low of $46 to a high of $75. The average price target represents a increase of $67.19 from the last closing price of $34.01.
The current UPSIDE for Agios Pharmaceuticals, Inc. (AGIO) is 67.19%
Based on short-term price targets offered by seven analysts, the average price target for Agios Pharmaceuticals comes to $56.86. The forecasts range from a low of $46.00 to a high of $75.00. The average price target represents an increase of 67.19% from the last closing price of $34.01.